Mani Foroohar

Mani Foroohar

Analyst-Equity chez
Leerink Partners LLC
Finance
Consumer Services

Profil

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A. from Columbia, and a B.S.
from UCLA.

Postes actifs de Mani Foroohar

SociétésPosteDébut
Analyst-Equity 01/05/2018

Anciens postes connus de Mani Foroohar

SociétésPosteFin
Analyst-Equity 01/12/2014
Analyst-Equity -
Voir l'expérience en détail de Mani Foroohar

Formation de Mani Foroohar

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

100 +

Relations au 1er degré

6

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées6

Finance

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

  1. Bourse
  2. Insiders
  3. Mani Foroohar
🔇